drugset

drugset / Trial / NCT00467259

Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women

NCT00467259 ↗

Phase 3 Completed 1271 enrolled Warner Chilcott

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is designed to evaluate the endometrial safety of a testosterone patch as treatment for low libido in naturally postmenopausal women.

Timeline

Start: 2007-04
Primary completion: 2009-01
Completion: 2009-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Testosterone	Small molecule	300 ug	Other

Indications